Viasat, the US satellite communications firm with significant UK government and military contracts, has filed a Form 144 with the Securities and Exchange Commission dated 3 June. The filing, a standard regulatory notice, signals that a company insider or major shareholder intends to sell restricted shares in the open market. While the exact volume and price remain undisclosed, such filings often precede a planned sale and can influence short-term share price movements.
The news arrives as the FTSE 100 closed at 8,254.18 points, down 0.3% on the day, while the FTSE 250 fell 0.5% to 20,612.40. Defence and aerospace stocks on the London market were mixed, with BAE Systems slipping 0.2% and Chemring Group flat. Viasat, which does not trade directly on the London Stock Exchange, is listed on the Nasdaq, where its shares have fallen 12% year-to-date amid broader tech sector headwinds.
Analysts at a London-based brokerage noted that Form 144 filings are routine but can spook investors if they involve large block sales. “Insider selling is not always bearish — it could be for personal liquidity or estate planning — but the market often reacts negatively to perceived supply overhang,” they said. For UK institutional investors and pension funds with indirect exposure via US-focused funds, the filing adds another layer of uncertainty to an already volatile satellite communications sector.
Contextually, Viasat has been expanding its UK footprint, including a partnership with the Ministry of Defence for secure satellite communications. However, the company has faced cost overruns on its ViaSat-3 satellite programme and rising debt levels. The Form 144 filing does not confirm a sale has occurred, only that the holder has registered the intention to sell. Investors are advised to watch for subsequent filings that will disclose actual transactions.
For UK investors holding shares in defence or satellite exchange-traded funds, the move could signal profit-taking or repositioning by major shareholders. It is not a direct indicator of company health but merits attention given the sector’s sensitivity to geopolitical spending shifts and interest rate changes.